Literature DB >> 1933012

Preventing osteoporosis.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933012      PMCID: PMC1671204     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Strategies for prevention of osteoporosis and hip fracture.

Authors:  M R Law; N J Wald; T W Meade
Journal:  BMJ       Date:  1991-08-24

2.  Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.

Authors:  C Christiansen; M S Christensen; I Transbøl
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

3.  The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.

Authors:  R E Johnson; E E Specht
Journal:  Am J Public Health       Date:  1981-02       Impact factor: 9.308

4.  Exercise and other factors in the prevention of hip fracture: the Leisure World study.

Authors:  A Paganini-Hill; A Chao; R K Ross; B E Henderson
Journal:  Epidemiology       Date:  1991-01       Impact factor: 4.822

5.  Menopausal estrogen therapy and hip fractures.

Authors:  A Paganini-Hill; R K Ross; V R Gerkins; B E Henderson; M Arthur; T M Mack
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

6.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

7.  An epidemiologic study of hip fracture in postmenopausal women.

Authors:  N Kreiger; J L Kelsey; T R Holford; T O'Connor
Journal:  Am J Epidemiol       Date:  1982-07       Impact factor: 4.897

8.  Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.

Authors:  N S Weiss; C L Ure; J H Ballard; A R Williams; J R Daling
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

9.  Bone response to termination of oestrogen treatment.

Authors:  R Lindsay; D M Hart; A MacLean; A C Clark; A Kraszewski; J Garwood
Journal:  Lancet       Date:  1978-06-24       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.